Volastra Therapeutics, a clinical-stage biotechnology company pioneering first-in-class therapies targeting chromosomal ...
SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Over the past decade, industry-sponsored clinical trial activity at UAB has grown steadily. To sustain and accelerate this momentum, the Clinical Trialist Development Program (CTDP) supports promising ...
The study was unlikely to meet its primary endpoint based on overall efficacy and safety results from a pre-planned futility analysis. BeiGene has made the decision to end the clinical development ...
The healthcare sector is facing a decisive moment. While nursing shortages continue to dominate national conversations and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...
The Modern Parenthood Institute provides research-aligned parent-education training and certification programs for ...
Charitharth Vivek Lal, M.D. is program director of the Golden Week Program™, an evidence-based, standardized, quality improvement plan, established and implemented at the UAB Regional Neonatal ...
WOBURN, Mass.--(BUSINESS WIRE)--ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today that Mr. Tom Shea ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback